Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for approximately 90% of all liver cancer cases. Given that the development ...
YKL-40 is an inflammatory biomarker linked to tumour progression in various cancers, and its levels are consistently elevated in patients with T2D, a condition linked to increased risks for multiple ...
Immunotherapy-based combinations have rapidly become the dominant first-line treatment for advanced hepatocellular carcinoma (HCC), but real-world outcomes remain heavily constrained by liver function ...
Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...
Scientists identify measurable cellular changes that flag higher cancer risk more than a decade before tumors appear. In A ...
Resilience may help alleviate the negative impact financial toxicity has on quality of life for individuals with primary liver cancer.A cross-sectional analysis showed positive correlations between ...